Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease

cGAMP-specific nucleases (poxins) are a recently described family of proteins dedicated to obstructing cyclic GMP-AMP synthase signaling (cGAS), an important sensor triggered by cytoplasmic viral replication that activates type I interferon (IFN) production. The B2R gene of vaccinia viruses (VACV) c...

ver descrição completa

Detalhes bibliográficos
Autores: Riederer, Stephanie; Canizo, Ana del; Navas, Javier; Peter, Marlowe G.; Link, Ellen K.; Sutter, Gerd; Rojas, Juan José
Tipo de documento: Artigo
Estado:Published version
Data de publicação:2023
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositório:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/202057
Acesso em linha:https://hdl.handle.net/2445/202057
Nível de acesso:Acesso aberto
Palavra-chave:Immunitat
Animals
Interferó
Nucleòtids
Immunity
Interferon
Nucleotides
_version_ 1878732006418808832
author Riederer, Stephanie
author2 Canizo, Ana del
Navas, Javier
Peter, Marlowe G.
Link, Ellen K.
Sutter, Gerd
Rojas, Juan José
author2_role author
author
author
author
author
author
author_browse Canizo, Ana del
Link, Ellen K.
Navas, Javier
Peter, Marlowe G.
Riederer, Stephanie
Rojas, Juan José
Sutter, Gerd
author_facet Riederer, Stephanie
Canizo, Ana del
Navas, Javier
Peter, Marlowe G.
Link, Ellen K.
Sutter, Gerd
Rojas, Juan José
author_role author
collection Recercat. Dipósit de la Recerca de Catalunya
description cGAMP-specific nucleases (poxins) are a recently described family of proteins dedicated to obstructing cyclic GMP-AMP synthase signaling (cGAS), an important sensor triggered by cytoplasmic viral replication that activates type I interferon (IFN) production. The B2R gene of vaccinia viruses (VACV) codes for one of these nucleases. Here, we evaluated the effects of inactivating the VACV B2 nuclease in the context of an oncolytic VACV. VACV are widely used as anti-cancer vectors due to their capacity to activate immune responses directed against tumor antigens. We aimed to elicit robust antitumor immunity by preventing viral inactivation of the cGAS/STING/IRF3 pathway after infection of cancer cells. Activation of such a pathway is associated with a dominant T helper 1 (Th1) cell differentiation of the response, which benefits antitumor outcomes. Deletion of the B2R gene resulted in enhanced IRF3 phosphorylation and type I IFN expression after infection of tumor cells, while effective VACV replication remained unimpaired, both in vitro and in vivo. In syngeneic mouse tumor models, the absence of the VACV cGAMP-specific nuclease translated into improved antitumor activity, which was associated with antitumor immunity directed against tumor epitopes.
eu_rights_str_mv openAccess
format article
id ES_3b0519888a9b5d9447d359d6c065eb2e
institution Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:recercat.cat:2445/202057
publishDate 2023
publishDateSort 2023
publisher Springer Nature
publisherStr Springer Nature
reponame_str Recercat. Dipósit de la Recerca de Catalunya
spelling Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease Riederer, Stephanie Canizo, Ana del Navas, Javier Peter, Marlowe G. Link, Ellen K. Sutter, Gerd Rojas, Juan José Immunitat Animals Interferó Nucleòtids Immunity Interferon Nucleotides cGAMP-specific nucleases (poxins) are a recently described family of proteins dedicated to obstructing cyclic GMP-AMP synthase signaling (cGAS), an important sensor triggered by cytoplasmic viral replication that activates type I interferon (IFN) production. The B2R gene of vaccinia viruses (VACV) codes for one of these nucleases. Here, we evaluated the effects of inactivating the VACV B2 nuclease in the context of an oncolytic VACV. VACV are widely used as anti-cancer vectors due to their capacity to activate immune responses directed against tumor antigens. We aimed to elicit robust antitumor immunity by preventing viral inactivation of the cGAS/STING/IRF3 pathway after infection of cancer cells. Activation of such a pathway is associated with a dominant T helper 1 (Th1) cell differentiation of the response, which benefits antitumor outcomes. Deletion of the B2R gene resulted in enhanced IRF3 phosphorylation and type I IFN expression after infection of tumor cells, while effective VACV replication remained unimpaired, both in vitro and in vivo. In syngeneic mouse tumor models, the absence of the VACV cGAMP-specific nuclease translated into improved antitumor activity, which was associated with antitumor immunity directed against tumor epitopes. Springer Nature https://hdl.handle.net/2445/202057
spellingShingle Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
Riederer, Stephanie
Immunitat
Animals
Interferó
Nucleòtids
Immunity
Interferon
Nucleotides
status_str publishedVersion
title Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
title_full Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
title_fullStr Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
title_full_unstemmed Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
title_short Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
title_sort Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease
topic Immunitat
Animals
Interferó
Nucleòtids
Immunity
Interferon
Nucleotides
topic_facet Immunitat
Animals
Interferó
Nucleòtids
Immunity
Interferon
Nucleotides
url https://hdl.handle.net/2445/202057